Volume | 4,162 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 3.325 | Mínimo Máximo |
|||||
Minimo del Dia | 3.1931 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Lixte Biotechnology Holdings Inc | LIXT | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
3.26 | 3.1931 | 3.325 | 3.26 | 3.22 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
59 | 4,162 | US$ 3.27 | US$ 13,603 | - | 1.58 - 9.50 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
15:55:06 | 2 | US$ 3.35 | USD |
Información Financiera Lixte Biotechnology Holdings Inc LIXT
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
7.33M | 2.25M | - | 0 | -5.09M | -2.26 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Lixte Biotechnology Holdings Inc LIXT
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
24/4/2024 | 14:25 | AllPennyStocks.com | Mixed Shelf Filing Gives Micro Cap Delayed Boost |
27/3/2024 | 14:35 | AllPennyStocks.com | Biotech Steals The Show Following Pre-Clinical Data.. |
27/3/2024 | 07:30 | GlobeNewswire Inc. | NEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD.. |
21/3/2024 | 07:30 | GlobeNewswire Inc. | LIXTE Provides Update on Progress with LB-100 as a PP2A.. |
27/2/2024 | 15:59 | Edgar (US Regulatory) | Form 8-K - Current report |
27/2/2024 | 07:30 | GlobeNewswire Inc. | Professor René Bernards to Present New Pre-Clinical Data on.. |
26/2/2024 | 09:48 | Edgar (US Regulatory) | Form 8-K - Current report |
26/2/2024 | 07:30 | GlobeNewswire Inc. | LIXTE Biotechnology Enters into Exclusive Immune Oncology.. |
29/1/2024 | 07:30 | GlobeNewswire Inc. | First Patient Dosed with LIXTE’s LB-100 and GSK’s.. |
28/11/2023 | 16:21 | Edgar (US Regulatory) | Form 8-K - Current report |
13/11/2023 | 13:28 | Edgar (US Regulatory) | Form 8-K - Current report |
13/11/2023 | 07:30 | GlobeNewswire Inc. | LIXTE Biotechnology Provides Update on Clinical Progress and.. |
Histórico de Datos LIXT
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 3.45 | 3.59 | 3.1048 | 3.28 | 20,698 | -0.19 | -5.51% |
1 Month | 3.27 | 3.87 | 2.9001 | 3.43 | 77,969 | -0.01 | -0.31% |
3 Months | 2.06 | 4.40 | 1.90 | 3.44 | 609,370 | 1.20 | 58.25% |
6 Months | 2.16 | 4.42 | 1.69 | 3.40 | 305,888 | 1.10 | 50.93% |
1 Year | 6.10 | 9.50 | 1.58 | 3.94 | 200,612 | -2.84 | -46.56% |
3 Years | 25.30 | 49.50 | 1.58 | 17.69 | 732,617 | -22.04 | -87.11% |
5 Years | 38.50 | 71.90 | 1.58 | 21.68 | 731,376 | -35.24 | -91.53% |